CD101
Basic information
Region (hg38): 1:117001750-117036552
Previous symbols: [ "IGSF2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD101 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 56 | 66 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 57 | 6 | 9 |
Variants in CD101
This is a list of pathogenic ClinVar variants found in the CD101 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-117001825-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
1-117009952-A-G | not specified | Uncertain significance (Dec 13, 2022) | ||
1-117010068-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
1-117010075-G-A | not specified | Likely benign (Jun 22, 2021) | ||
1-117010116-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
1-117010183-C-A | not specified | Uncertain significance (May 11, 2022) | ||
1-117010186-A-G | not specified | Uncertain significance (Dec 19, 2023) | ||
1-117011696-G-A | not specified | Uncertain significance (Oct 19, 2021) | ||
1-117011711-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
1-117011771-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
1-117011799-A-G | Benign (Feb 23, 2021) | |||
1-117011856-A-G | not specified | Uncertain significance (Mar 02, 2023) | ||
1-117011864-C-A | not specified | Uncertain significance (Jan 20, 2023) | ||
1-117011869-C-A | not specified | Uncertain significance (Dec 13, 2021) | ||
1-117011913-T-A | not specified | Uncertain significance (Jan 17, 2024) | ||
1-117011959-G-C | not specified | Uncertain significance (Dec 14, 2023) | ||
1-117013503-A-G | Likely benign (May 08, 2018) | |||
1-117013639-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
1-117013649-T-C | Benign (May 16, 2018) | |||
1-117013720-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
1-117013724-C-A | not specified | Uncertain significance (Oct 18, 2021) | ||
1-117013754-A-G | not specified | Uncertain significance (Aug 16, 2022) | ||
1-117017147-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
1-117017258-A-T | not specified | Uncertain significance (Mar 15, 2023) | ||
1-117017402-C-G | not specified | Uncertain significance (Jan 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD101 | protein_coding | protein_coding | ENST00000256652 | 9 | 34786 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.28e-13 | 0.972 | 125450 | 0 | 298 | 125748 | 0.00119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.360 | 528 | 552 | 0.957 | 0.0000291 | 6644 |
Missense in Polyphen | 117 | 131.43 | 0.89022 | 1657 | ||
Synonymous | 0.292 | 217 | 223 | 0.975 | 0.0000124 | 2022 |
Loss of Function | 2.35 | 27 | 43.8 | 0.616 | 0.00000202 | 518 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00239 | 0.00239 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00131 | 0.00131 |
Finnish | 0.00342 | 0.00342 |
European (Non-Finnish) | 0.000936 | 0.000932 |
Middle Eastern | 0.00131 | 0.00131 |
South Asian | 0.000392 | 0.000392 |
Other | 0.00228 | 0.00228 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role as inhibitor of T-cells proliferation induced by CD3. Inhibits expression of IL2RA on activated T-cells and secretion of IL2. Inhibits tyrosine kinases that are required for IL2 production and cellular proliferation. Inhibits phospholipase C-gamma-1/PLCG1 phosphorylation and subsequent CD3- induced changes in intracellular free calcium. Prevents nuclear translocation of nuclear factor of activated T-cell to the nucleus. Plays a role in the inhibition of T-cell proliferation via IL10 secretion by cutaneous dendritic cells. May be a marker of CD4(+) CD56(+) leukemic tumor cells. {ECO:0000269|PubMed:11093127, ECO:0000269|PubMed:15737213, ECO:0000269|PubMed:7722299, ECO:0000269|PubMed:9233604, ECO:0000269|PubMed:9389317, ECO:0000269|PubMed:9647226}.;
- Pathway
- Generation of second messenger molecules;TCR signaling;Immune System;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.624
- rvis_EVS
- 1.68
- rvis_percentile_EVS
- 96.34
Haploinsufficiency Scores
- pHI
- 0.128
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.392
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd101
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- positive regulation of myeloid leukocyte differentiation;cell surface receptor signaling pathway
- Cellular component
- plasma membrane;integral component of membrane;extracellular exosome
- Molecular function
- hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides